MRNA 8-K 2026-09-30
Moderna, Inc. (MRNA) 8-K dated 2026-09-30 — accession 0001193125-26-408289.
Moderna, Inc. (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Moderna, Inc. filed a 8-K on 2026-09-30. Accession 0001193125-26-408289.
This 8-K covers: Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
Not investment advice. The MRNA SEC hub lists recent forms. The stock page is the research view.